Quick approval for second hospital to use Ivermectin in the Philippines

Source: Philstar Author: Sheila Crisostomo

MANILA, Philippines — Another private hospital was given a compassionate special permit (CSP) to use Ivermectin as treatment for COVID-19 patients, the Food and Drug Administration (FDA) said yesterday.

According to FDA director general Eric Domingo, there are now two private hospitals, which he refused to identify, that can use the mainly veterinary drug to treat their COVID-19 patients.

“As of (Thursday), there was a second hospital applicant for CSP. (Yesterday) morning, it was approved already,” he noted.

The CSP is valid for one year and can only be used by doctors of these hospitals.

Under the protocols, hospitals granted a CSP can use Ivermectin on an indicated number of patients. Once they consume the number of patients in their application, they can apply for CSP again.

Related: More Vaccine Blood Clots – Craig Kelly Backed Up By Medical Specialists Supporting Ivermectin!

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Dr. Peter McCullough blames high COVID death toll on massive censorship of effective early treatment protocols such as hydroxychloroquine & ivermectin

SUCCESS: SETTLEMENT REGARDING IVERMECTIN NOW AN ORDER OF COURT – South Africa

Argentina Ministry of Health Clinical Trial: Ivermectin Shows Benefit Treating Outpatients with Mild COVID-19

Top Yale Doctor/Researcher: ‘Ivermectin works,’ including for long-haul COVID